27 Jan 2018
Reply
Enquiry// Doxorubicin liposomal finished formulations needed in Colombia [ENA00677]
A company dedicated to accompanying the pharmaceutical industry to develop innovative portfolios, with the help of its allies is looking for Doxorubicin liposomal injections for supply to one of their clients in Colombia. The quantity required is as follows:
1. PA Doxorubicin 10 mg Vial 7,210 units
2. RD Doxorubicin 10 mg 446 units
3. RD Doxorubicin 50 mg 373 units
4. GT Doxorubicin 10 mg Vial 4,927 units
5. HN Doxorubicin 10 mg Vial 1,260 units
6. SV Doxorubicin 10 mg 1,950 units
The products must be from a facility that is GMP approved by Invima, US FDA, EU GMP, TGA, MHRA, Health Canada, Japan or Copefris, in addition, CPP and dossiers are also necessary.
1. PA Doxorubicin 10 mg Vial 7,210 units
2. RD Doxorubicin 10 mg 446 units
3. RD Doxorubicin 50 mg 373 units
4. GT Doxorubicin 10 mg Vial 4,927 units
5. HN Doxorubicin 10 mg Vial 1,260 units
6. SV Doxorubicin 10 mg 1,950 units
The products must be from a facility that is GMP approved by Invima, US FDA, EU GMP, TGA, MHRA, Health Canada, Japan or Copefris, in addition, CPP and dossiers are also necessary.
export@healthpharma.in
Dear Sir,
Greetings from Health Pharma...!!!
We can support you for asked product. kindly request you to send detailed email for further discussion.
Awaiting your response.
20:08, 11 Jul 2019
